HOME >> BIOLOGY >> NEWS
Cell Suicide Prevented By Survival Signals

Cell Suicide Prevented by Survival Signals

October 29, 1998—As most cells age or become damaged, a genetic program triggers their self-destruction. This "programmed" cell death performs a critical housekeeping function that prevents damaged, malfunctioning or misplaced cells from causing future harm.

In some instances, however, the death sentence is commuted and certain cells cheat death. How this happens is still largely a mystery, but recent findings from the laboratory of Hermann Steller, an HHMI investigator at the Massachusetts Institute of Technology, may offer new insight. In the October 29, 1998, issue of the journal Cell, Steller's team defines a precise molecular target that allows cells from the fruit fly Drosophila to survive in the presence of death-inducing stimuli.

For the last several years, influential researchers such as Martin Raff of the Medical Research Council Laboratory for Molecular Cell Biology at University College in London, have advanced the idea that the survival of all cells is governed by "social controls" that exert their effects via extracellular signals. An extreme view of social control, noted by Raff in a 1992 Nature review article, is the notion that "just as a cell seems to need signals from other cells in order to proliferate, so it needs signals from other cells in order to survive."

"It seems that cell survival and cell death are subject to the same kinds of social controls that operate on cell proliferation; yet compared with the control of cell proliferation, relatively little is known about the control of cell survival," writes Raff in Nature.

Cancer cells provide one of the best examples of this theory in action, says Steller. "At some point during tumorigenesis, every cancer cell achieves some independence from extracellular survival factors, that is, it escapes the 'soci
'"/>

Contact: Jim Keeley
keeleyj@hhmi.org
301-215-8858
Howard Hughes Medical Institute
29-Oct-1998


Page: 1 2 3 4

Related biology news :

1. Suicide proteins contribute to sperm creation
2. Experimental Therapy Makes HIV-Infected Cells Commit Suicide
3. Study Documents Attitudes About Assisted Suicide Among Patients With Lou Gehrigs Disease
4. Suicide Response Gives Colorado State Researchers Important Clues On Preventing Bacterial Invasion In Crops Worldwide
5. Stopping "Cellular Suicide" Could Boost Production In Biotech Labs
6. U.S. In The Midst Of A Heroin Epidemic, But Many Overdose Deaths Can Be Prevented
7. Relapses Prevented In Mouse Model Of Multiple Sclerosis: Research Aimed At Treating Relapses In Human MS
8. Survival strategies in nature
9. Survival of the fastest: scientists selectively breed winning Formula One cars
10. Ecology lab aids Turtle Survival Alliance
11. Survival tactics in bacteria - environmental conditions fit for mankind

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Cell Suicide Prevented Survival Signals

(Date:5/22/2013)... YORK, May 22, 2013. Plastic additives known as ... about everywhere: They turn up in flooring, plastic ... to the Centers for Disease Control and Preventionthe ... phthalates have come under increasing scrutiny. A growing ... (which can leech from packaging and mix with ...
(Date:5/21/2013)... infections occur in the body, stem cells in ... and differentiating into mature immune cells that can ... can deplete these cell populations, potentially leading to ... cancer. Now, a team of researchers led by ... has found that, in mouse models, the molecule ...
(Date:5/21/2013)... Widely available in pharmacies and health stores, phosphatidylserine ... oysters, and soy. Proven to improve cognition and ... older people experiencing memory impairment. Now a team ... Bochner of Tel Aviv University,s Department of ... same supplement improves the functioning of genes involved ...
Breaking Biology News(10 mins):Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 2
(Date:5/21/2013)... (PRWEB) May 21, 2013 ... services company for clinical trials, announced today it ... Solutions, LLC. Clinverse’s ClinPay® FLS eClinical commerce ... payment process. SpendMD ™, Aggregate Spend ... solution for tracking and reporting transfer of value ...
(Date:5/21/2013)... May 21, 2013 According to ... ( http://www.transparencymarketresearch.com ) "Biochip Products and Services Market (Microarrays, ... Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the ... and is expected to grow at a CAGR of ... value of USD 4.7 billion in 2018. ...
(Date:5/21/2013)... May 21, 2013 Many have long ... contributor to acne. Recently physicians from Clinical Psychiatry.com ... stress on the skin, and suggested using hypnotherapy ... the chemicals produced from stress that cause acne. , ... negative feelings acne brings about, stress causes changes in ...
(Date:5/21/2013)... , May 21, 2013  MacroGenics, Inc. ... study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal ... expressing the HER2 oncoprotein," will be presented at ... of Clinical Oncology during the Developmental Therapeutics - ... at 4:15 – 4:30 PM.  The presentation will ...
Breaking Biology Technology:Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: